Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
Last verified by NonDilute: 2026-04-29. Official notice and agency instructions control.
If you have a lab-developed diagnostic or treatment technology and want an academic or industry partner to co-develop it toward clinical use, this NIH program funds exactly that translation step.
Report stale or inaccurate summary
What this is
This NCI-led initiative funds translation of research discoveries into practical diagnostic and therapeutic technologies applicable in pre-clinical, clinical, and non-clinical settings. The award supports academic institutions and for-profit organizations collaborating to de-risk and advance technologies addressing unmet needs in disease assessment, prevention, diagnosis, treatment, and management. Up to $499k available. Clinical trial participation is optional. Open to universities, nonprofits, small businesses, and established companies.
Who can apply
Eligible applicants include universities (public and private), nonprofits with or without 501(c)(3) status, small businesses, for-profit companies, tribal organizations, and state/local governments. Solo founders are generally ineligible unless operating as a registered small business or nonprofit; university researchers and established companies are preferred applicant types.
Eligible applicant types
- Small businesses
- City or township governments
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Public housing authorities/Indian housing authorities
- Independent school districts
- County governments
- Special district governments
- State governments
- Public and State controlled institutions of higher education
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- For profit organizations other than small businesses
- Native American tribal governments (Federally recognized)
Full description — from the agency
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. The rationale is to deliver new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and delivery of care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating institutes.
Topics: technology translation · diagnostic tools · disease treatment · academic-industry partnership · clinical innovation · biotech commercialization
Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.